TANG PRIZE/Tang Prize laureate happy his research may save COVID-19 patients
06/19/2020 10:43 PM
Japanese immunologist Kishimoto Tadamitsu, one of the co-winners of the 2020 Tang Prize in biopharmaceutical science, was very happy that his early research has shown potential in saving COVID-19 patients from dying due to complications.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
More in TANG PRIZE
- Drugs treating diabetes, obesity can do more: Tang Prize laureatesSvetlana Mojsov and Jens Juul Holst, two of the laureates of the 2024 Tang Prize in Biopharmaceutical Science, said at a forum in Taichung on Tuesday that the GLP-1-based drugs their research spawned could go beyond managing diabetes and obesity.10/01/2024 08:52 PM
- Tang Prize winner lauds Taiwan implementation of human rights covenantsFormer Irish President Mary Robinson on Monday praised Taiwan's efforts to incorporate international covenants on human rights into its domestic law despite not being a signatory.09/30/2024 08:58 PM
- Historian shares research into ancient Chinese myth at Tang Prize forumRenowned Taiwanese-American historian Hsu Cho-yun (許倬雲) on Monday said his work regarding the ancient Chinese myth Da Yu (大禹) was a successful example of integrating social science methodologies into historical research that helped him win the 2024 Tang Prize in Sinology.09/30/2024 01:52 PM
Latest
- Science & Tech
Hon Hai's research arm unveils AI-related technologies
06/16/2025 07:40 PM - Politics
4 KMT staff, 1 activist charged for recall vote forgeries in Taipei
06/16/2025 07:19 PM - Cross-Strait
Ex-US Navy intel chief advises strategic messaging amid 'first shot' dilemma
06/16/2025 05:42 PM - Society
CGA urges public to use ocean safety app after drowning incidents
06/16/2025 05:37 PM - Business
Number of furloughed workers up due to U.S. tariff impact
06/16/2025 05:19 PM